Abstract
Opponents to parallel trade claim that it is highly inefficient and that savings to the consumers are only a fraction of the profits to the middlemen. Advocates oppose that savings to the consumers are high and profit margins of parallel traders low. This chapter looks at evidence on consumer gains and parallel distribution mark ups from the past decade. It shows how these figures have evolved over time and draws conclusions on the future development of the ratio between parallel distribution mark-ups and consumer gains.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Reference
Glynn D. et al. (1997), Survey of parallel trade, Pages 8, 16
Kanavos P. and Costa-Font J (2005), Pharmaceutical parallel trade in Europe: stakeholder and competition effects, Economic Policy October 2005, p 778
Pedersen K. et al. (2006), The Economic Impact of parallel import of pharmaceuticals, University of Southern Denmark
European Court of Justice (2004), Judgement of the Court in joined cases C-2/01 P and C-3/01 P
Court of First Instance of the ECJ (2006), Judgment of the court of first instance in case T-168/01
Rights and permissions
Copyright information
© 2008 Birkhäuser Verlag AG
About this chapter
Cite this chapter
(2008). Welfare effects of parallel trade. In: Parallel Imports of Pharmaceuticals. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-8589-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-7643-8589-7_7
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-8588-0
Online ISBN: 978-3-7643-8589-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)